Return to Process Development Services
We apply Best Practices in Process Development when helping our clients establish scalable and cost effective manufacturing processes for their autologous or allogeneic cellular therapies. Lonza works with therapeutic companies to understand their current manufacturing process, the cell and product characteristics that are critical to maintain during process development, as well as their target cost of goods (CoGs). We then perform a scalability evaluation and develop process models to help guide decision making towards scalable, cost efficient processes that can be manufactured at the scales required for mid-to-late stage clinical trials as well as during the commercial introduction of this new class of therapies.
The following are the technology platforms and services that we provide:
Allogeneic – Scale-up Processes